The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience
Open accessAbstract
Guillain‐Barré syndrome (GBS) is an inflammatory polyradiculoneuropathy associated with numerous viral infections. Recently, there have been many case reports describing the association between coronavirus disease‐2019 (COVID‐19) and GBS, but much remains unknown about the strength of the association and the features of GBS in this setting. We reviewed 37 published cases of GBS associated with COVID‐19 to summarize this information for clinicians and to determine whether a specific clinical or electrodiagnostic (EDx) pattern is emerging. The mean age (59 years), gender (65% male), and COVID‐19 features appeared to reflect those of hospitalized COVID‐19 patients early in the pandemic. The mean time from COVID‐19 symptoms to GBS symptoms was 11 days. The clinical presentation and severity of these GBS cases was similar to those with non–COVID‐19 GBS. The EDx pattern was considered demyelinating in approximately half of the cases. Cerebrospinal fluid, when assessed, demonstrated albuminocytologic dissociation in 76% of patients and was negative for severe acute respiratory distress syndrome–coronavirus‐2 (SARS‐CoV‐2) in all cases. Serum antiganglioside antibodies were absent in 15 of 17 patients tested. Most patients were treated with a single course of intravenous immunoglobulin, and improvement was noted within 8 weeks in most cases. GBS‐associated COVID‐19 appears to be an uncommon condition with similar clinical and EDx patterns to GBS before the pandemic. Future studies should compare patients with COVID‐19–associated GBS to those with contemporaneous non–COVID‐19 GBS and determine whether the incidence of GBS is elevated in those with COVID‐19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Ye, Q., Wang, B., & Mao, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.037 · Cited by 2,761
Cao-Lormeau, V.-M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00562-6 · Cited by 2,205
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., De Leacy, R. A., Shigematsu, T., Ladner, T. R., Yaeger, K. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,116
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009575 · Cited by 1,439
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30109-5 · Cited by 993
Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis
Sejvar, J. J., Baughman, A. L., Wise, M., & Morgan, O. W. (2011) · Neuroepidemiology · doi:10.1159/000324710 · Cited by 960
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Neuropathological features of Covid-19
Solomon, I. H., Normandin, E., Bhattacharyya, S., Mukerji, S. S., Keller, K., Ali, A. S., Adams, G., Hornick, J. L., Padera, R. F., & Sabeti, P. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2019373 · Cited by 815 · cited 1×
“CSF from these COVID-19–associated GBS patients was negative for SARSCoV-2 by RT-PCR, and postmortem brain tissues from COVID-19 patients did not show evidence of viral infection by immunohistochemical analysis.(49) GBS is a postinfectious syndrome as defined by an onset that is delayed from the acute symptoms of infe…”
MethodMiller Fisher syndrome and polyneuritis cranialis in COVID-19
Gutiérrez-Ortiz, C., Méndez-Guerrero, A., Rodrigo-Rey, S., San Pedro-Murillo, E., Bermejo-Guerrero, L., Gordo-Mañas, R., de Aragón-Gómez, F., & Benito-León, J. (2020) · Neurology · doi:10.1212/wnl.0000000000009619 · Cited by 810
Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria
Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P. A., & Jacobs, B. C. (2014) · Brain · doi:10.1093/brain/awt285 · Cited by 792
SCHONBERGER, L. B., BREGMAN, D. J., SULLIVAN-BOLYAI, J. Z., KEENLYSIDE, R. A., ZIEGLER, D. W., RETAILLIAU, H. F., EDDINS, D. L., & BRYAN, J. A. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112795 · Cited by 785
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
Guillain Barre syndrome associated with COVID-19 infection: A case report
Sedaghat, Z., & Karimi, N. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.04.062 · Cited by 575
Avula, A., Nalleballe, K., Narula, N., Sapozhnikov, S., Dandu, V., Toom, S., Glaser, A., & Elsayegh, D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.077 · Cited by 558
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 505
Neurological complications during treatment of middle east respiratory syndrome
Kim, J.-E., Heo, J.-H., Kim, H.-O., Song, S.-H., Park, S.-S., Park, T.-H., Ahn, J.-Y., Kim, M.-K., & Choi, J.-P. (2017) · Journal of Clinical Neurology · doi:10.3988/jcn.2017.13.3.227 · Cited by 497
Convalescent plasma in Covid-19: Possible mechanisms of action
Rojas, M., Rodríguez, Y., Monsalve, D. M., Acosta-Ampudia, Y., Camacho, B., Gallo, J. E., Rojas-Villarraga, A., Ramírez-Santana, C., Díaz-Coronado, J. C., Manrique, R., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102554 · Cited by 491
Hess, D. C., Eldahshan, W., & Rutkowski, E. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00818-9 · Cited by 381
Guillain-Barré syndrome related to COVID-19 infection
Alberti, P., Beretta, S., Piatti, M., Karantzoulis, A., Piatti, M. L., Santoro, P., Viganò, M., Giovannelli, G., Pirro, F., Montisano, D. A., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000741 · Cited by 335
Guillain-Barré Syndrome Following Influenza Vaccination
Haber, P. (2004) · JAMA · doi:10.1001/jama.292.20.2478 · Cited by 254
Dalakas, M. C. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000781 · Cited by 253
Guillain-Barré Syndrome associated with SARS-CoV-2 infection
Virani, A., Rabold, E., Hanson, T., Haag, A., Elrufay, R., Cheema, T., Balaan, M., & Bhanot, N. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00771 · Cited by 252
Guillain-Barre Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence
Vellozzi, C., Iqbal, S., & Broder, K. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu005 · Cited by 215
Guillain-Barré syndrome following COVID-19: new infection, old complication?
Padroni, M., Mastrangelo, V., Asioli, G. M., Pavolucci, L., Abu-Rumeileh, S., Piscaglia, M. G., Querzani, P., Callegarini, C., & Foschi, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09849-6 · Cited by 199
COVID-19 may induce Guillain–Barré syndrome
Camdessanche, J.-P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.04.003 · Cited by 189
Guillain‐Barr é syndrome during SARS‐CoV‐2 pandemic: A case report and review of recent literature
Scheidl, E., Canseco, D. D., Hadji‐Naumov, A., & Bereznai, B. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12382 · Cited by 185
Ma, J., Xia, P., Zhou, Y., Liu, Z., Zhou, X., Wang, J., Li, T., Yan, X., Chen, L., Zhang, S., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108408 · Cited by 171
Ottaviani, D., Boso, F., Tranquillini, E., Gapeni, I., Pedrotti, G., Cozzio, S., Guarrera, G. M., & Giometto, B. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04449-8 · Cited by 159
Guillain‐Barré Syndrome and Influenza Virus Infection
Sivadon‐Tardy, V., Orlikowski, D., Porcher, R., Sharshar, T., Durand, M., Enouf, V., Rozenberg, F., Caudie, C., Annane, D., van der Werf, S., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/594124 · Cited by 152
Neuromuscular Manifestations of West Nile Virus Infection
Leis, A. A., & Stokić, D. S. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00037 · Cited by 143
T-Cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barr� syndrome
Hartung, H., & Toyka, K. V. (1990) · Annals of Neurology · doi:10.1002/ana.410270716 · Cited by 137
Covid-19 and Guillain-Barré syndrome: More than a coincidence!
Otmani, H. E., Moutawakil, B. E., Rafai, M. A., Benna, N. E., Kettani, C. E., Soussi, M., Mdaghri, N. E., Barrou, H., & Àfif, H. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.04.007 · Cited by 136
COVID-19–Associated Miller Fisher Syndrome: MRI Findings
Lantos, J. E., Strauß, S., & Lin, E. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6609 · Cited by 131
Caamaño, D. S. J., & Beato, R. A. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.05.016 · Cited by 128
Fantini, J., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106020 · Cited by 128
Guillain-Barré syndrome as a complication of SARS-CoV-2 infection
Coen, M., Jeanson, G., Almeida, L., Hübers, A., Stierlin, F., Najjar, I., Ongaro, M., Moulin, K., Makrygianni, M., Leemann, B., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.074 · Cited by 109
Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication
Webb, S., Wallace, V. C. J., Martín-López, D., & Yogarajah, M. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236182 · Cited by 102
Miller‐Fisher syndrome after SARS‐CoV‐2 infection
Bueno, J. A. R., Trujillo, L. G., Urbaneja, P., Ciano-Petersen, N. L., Postigo-Pozo, M. J., Martínez‐Tomás, C., & Serrano-Castro, P. J. (2020) · European Journal of Neurology · doi:10.1111/ene.14383 · Cited by 98
Post SARS-CoV-2 Guillain-Barré syndrome
Arnaud, S., Budowski, C., Tin, S. N. W., & Degos, B. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.05.003 · Cited by 84
Complications of Plasma Exchange in Neurological Patients
Rodnitzky, R. L., & Goeken, J. A. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510180028007 · Cited by 81
Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report
Sharma, K., Tengsupakul, S., Sanchez, O., Phaltas, R., & Maertens, P. M. (2019) · SAGE Open Medical Case Reports · doi:10.1177/2050313x19838750 · Cited by 77
Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection
Chan, J. L., Ebadi, H., & Sarna, J. R. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.106 · Cited by 72
SARS‐CoV‐2 and Guillain–Barré syndrome: AIDP variant with a favourable outcome
Lascano, A. M., Epiney, J., Coen, M., Serratrice, J., Bernard‐Valnet, R., Lalive, P. H., Küntzer, T., & Hübers, A. (2020) · European Journal of Neurology · doi:10.1111/ene.14368 · Cited by 72
Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection
Saldaña, A. S., Gil, Á. L., Liesa, J. L. C., Caballo, M. R. B., Haddad-Garay, M., Rivero-Celada, D., & Ponz, M. S. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0213 · Cited by 69
Guillain–Barré syndrome after SARS‐CoV‐2 infection
Kilinc, D., van de Pasch, S., Doets, A. Y., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14398 · Cited by 51
Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2
Helbok, R., Beer, R., Löscher, W. N., Boesch, S., Reindl, M., Hornung, R., Schiefecker, A. J., Deisenhammer, F., & Pfausler, B. (2020) · European Journal of Neurology · doi:10.1111/ene.14388 · Cited by 50
Seasonal influenza vaccine and Guillain-Barré syndrome
Grave, C., Boucheron, P., Rudant, J., Mikaeloff, Y., Tubert-Bitter, P., Escolano, S., Hocine, M., Coste, J., & Weill, A. (2020) · Neurology · doi:10.1212/wnl.0000000000009180 · Cited by 33
Guillain-Barré syndrome and SARS-CoV-2
Lampe, A. K., Winschel, A., Lang, C., & Steiner, T. (2020) · Neurological Research and Practice · doi:10.1186/s42466-020-00066-0 · Cited by 27
Jin, P. H., Shin, S. C., & Dhamoon, M. S. (2020) · Muscle & Nerve · doi:10.1002/mus.26884 · Cited by 19
Cited by
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
Harapan, B. N., & Yoo, H. J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10406-y · Cited by 359
Systemic and organ-specific immune-related manifestations of COVID-19
Ramos-Casals, M., Brito-Zerón, P., & Mariette, X. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00608-z · Cited by 309
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung
Bulfamante, G., Bocci, T., Falleni, M., Campiglio, L., Coppola, S., Tosi, D., Chiumello, D., & Priori, A. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10604-8 · Cited by 83
Metadata
- Authors
- Caress, J. B., Castoro, R. J., Simmons, Z., Scelsa, S. N., Lewis, R. A., Ahlawat, A., & Narayanaswami, P.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2020-08-11
- Volume
- 62
- Issue
- 4
- Pages
- 485-491
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W3043251744
- Cited by
- 280
- References
- 54
- FWCI
- 21.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.